We often think of gene-disease validity (GDV) in terms of new and rare disease. However, GDV analysis is ongoing as new data becomes available. When assessing GDV for a very common disease like breast cancer, multiple factors must be considered and associations may be recategorized over time. Explore this topic with Jennifer Herrera-Mullar, MGC, CGC, DMA. #breastcancer #hereditarycancer #genetictesting #AmbryKnowsGenes https://hubs.ly/Q02ChGy60
Ambry Genetics’ Post
More Relevant Posts
-
Check out today's podcast episode of DNA Today with Ambry's Dr. Elizabeth Chao and Kelly Hagman!
🔬 We dive into how #exomes are continuously analyzed through Ambry Genetics' “Patient for Life” program! 🧬 🎙️ Episode #295 of the DNA Today podcast explores the incredible advancements in exome sequencing with Ambry Genetics' “Patient for Life” program. Join Elizabeth Chao, MD, FACMG and Kelly Hagman, MS, CGC as they discuss how continuous reanalysis improves patient care. Search “DNA Today” in your podcast player and stream Episode 295 🎧 https://lnkd.in/e3FQHDyc #Genetics #ExomeSequencing #PatientCare #SciencePodcast
-
In her role as a breast health navigator in a large health system, Adrianne Alexander was tasked with the development of a high-risk breast cancer program. She was thankful to find the right partner in the Ambry CARE Program®. We love to work with providers like Adrianne to ensure more patients have access to high risk screening, genetic testing, and genetic counseling as part of their healthcare journeys. #breastcancer #genetictesting #CARE
-
-
Join us for a webinar, Thursday, July 11, 2024, at 11:00am PDT. https://hubs.ly/Q02FY7Ls0
-
-
The Ambry Classifi™️ Program is committed to providing the right answer, the first time. Our variant classification team leverages the best of both people and process to ensure an advanced scientific approach. Hear more from Dr. Rhonda Lassiter, leader of the Genomic Science Development Program at Ambry. Learn more and watch the full video here: https://hubs.ly/Q02FHmXW0
-
Patient for Life™ turns every exome into a living test. Ambry continues to search for answers for patients and proactively issues updated reports as new gene-disease associations are validated. Learn more about how our commitment to patients makes a difference: https://hubs.ly/Q02F23yS0 #PatientforLife #exome #raredisease #neurology #VUS
-
-
Ambry has been named a 2024 Best Company for Career Growth by Comparably. Find out what some of our employees love about working at #AmbryGenetics. #OneAmbry https://hubs.ly/Q02F7Ty00
Ambry Genetics - Best Company for Career Growth Award CC
https://vimeo.com/
-
Are you a recent Genetic Counseling grad? Join our genetic science liaisons at Ambry's Summer Genetic Counseling Boards Review! We've helped hundreds study with this trivia-style event. Register at https://hubs.ly/Q02DJkxM0 for the session that fits your schedule. All sessions feature the same content. #genechat #geneticcounseling #boardsreview
-
-
Happy Fourth of July! We are grateful for our team and the providers we work with. Their dedication to science and passion for patients are as bright as fireworks in the sky. Thank you for shaping our success with every contribution. #TeamAmbry #IndependenceDay
-
Lynch syndrome is the most common cause of hereditary colorectal cancer. In 2020, Ambry incorporated a tumor characteristic likelihood ratio (TCLR) into the variant assessment framework. Jessica Grzybowski, MS, CGC, explains how TCLR helps Ambry provide more answers to healthcare providers and their patients. #Lynchsyndrome #colorectalcancer #genetictesting https://hubs.ly/Q02DHTtt0
-
-
In the ever-evolving field of #genetics, understanding the relationship between genes and diseases is crucial for improving patient care. Join Jennifer Herrera-Mullar to explore the importance of gene-validity scoring, the evolution of GDV frameworks and the future of #GDV curation. https://hubs.ly/Q02DH-K80
-
